Cancer incidence and cancer death in relation to tobacco smoking in a population-based Australian cohort study
- PMID: 34015143
- DOI: 10.1002/ijc.33685
Cancer incidence and cancer death in relation to tobacco smoking in a population-based Australian cohort study
Abstract
Tobacco smoke is a known carcinogen, but the magnitude of smoking-related cancer risk depends on country-specific, generational smoking patterns. We quantified cancer risk in relation to smoking in a population-based cohort, the 45 and Up Study (2006-2009) in New South Wales, Australia. Cox proportional hazards regressions estimated adjusted hazard ratios (HR) by self-reported smoking history at baseline (2006-2009) for incident, primary cancers via linkage to cancer registry data to 2013 and cancer death data to 2015. Among 229 028 participants aged ≥45 years, 18 475 cancers and 5382 cancer deaths occurred. Current-smokers had increased risks of all cancers combined (HR = 1.42, 95% confidence interval [CI], 1.34-1.51), cancers of the lung (HR = 17.66, 95%CI, 14.65-21.29), larynx (HR = 11.29, 95%CI, 5.49-23.20), head-and-neck (HR = 2.53, 95%CI, 1.87-3.41), oesophagus (HR = 3.84, 95%CI, 2.33-6.35), liver (HR = 4.07, 95%CI, 2.55-6.51), bladder (HR = 3.08, 95%CI, 2.00-4.73), pancreas (HR = 2.68, 95%CI, 1.93-3.71), colorectum (HR = 1.31, 95%CI, 1.09-1.57) and unknown primary site (HR = 3.26, 95%CI, 2.19-4.84) versus never-smokers. Hazards increased with increasing smoking intensity; compared to never-smokers, lung cancer HR = 9.22 (95%CI, 5.14-16.55) for 1-5 cigarettes/day and 38.61 (95%CI, 25.65-58.13) for >35 cigarettes/day. Lung cancer risk was lower with quitting at any age but remained higher than never-smokers for quitters aged >25y. By age 80y, an estimated 48.3% of current-smokers (41.1% never-smokers) will develop cancer, and 14% will develop lung cancer, including 7.7% currently smoking 1-5 cigarettes/day and 26.4% for >35 cigarettes/day (1.0% never-smokers). Cancer risk for Australian smokers is significant, even for 'light' smokers. These contemporary estimates underpin the need for continued investment in strategies to prevent smoking uptake and facilitate cessation, which remain key to reducing cancer morbidity and mortality worldwide.
Keywords: cancer incidence; cancer mortality; cohort study; lifetime risk; smoking; tobacco.
© 2021 UICC.
References
REFERENCES
-
- International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal Habits and Indoor Combustions. Volume 100E A Review of Human Carcinogens. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 100E; 2012.
-
- Wenbin D, Zhuo C, Zhibing M, et al. The effect of smoking on the risk of gallbladder cancer: a meta-analysis of observational studies. Eur J Gastroenterol Hepatol. 2013;25:373-379. https://doi.org/10.1097/meg.0b013e32835a870b.
-
- Kaaks R, Sookthai D, Hemminki K, et al. Risk factors for cancers of unknown primary site: Results from the prospective EPIC cohort. Int J Cancer. 2014;135:2475-2481. https://doi.org/10.1002/ijc.28874.
-
- Thun MJ, Carter BD, Feskanich D, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368:351-364. https://doi.org/10.1056/nejmsa1211127.
-
- Thun M, Peto R, Boreham J, Lopez AD. Stages of the cigarette epidemic on entering its second century. Tobacco Control. 2012;21:96-101. https://doi.org/10.1136/tobaccocontrol-2011-050294.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
